Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 3 March 2023, 09:18 HKT/SGT
Share:
H World Group sells its shares in Accor, both companies to continue partnership in developing their hotel operations in China

HONG KONG, Mar 3, 2023 - (ACN Newswire) - H World Group recently announced that it completed the disposal of its 3.7% stake in Accor. The proceeds of this transaction will be redeployed for the development of the Group's core business. After this transaction, H World Group no longer owns any stake in Accor, but both sides will continue to develop their successful partnership.

As world-renowned hotel groups, H World Group and Accor established strategic partnership with cross shareholding in 2016. Under the agreement, H World Group has the master franchisee rights for Mercure, Ibis and Ibis Styles, as well as co-development rights for Grand Mercure and Novotel in the Greater China Region. By the end of 2022, H World Group operates 468 hotels in China under this agreement, with 143 properties in the pipeline scheduled to open over the next few years. Accor remains a key partner of H World Group in China as both sides push forth their efforts to expand and innovate in the hospitality industry.

H World Group is a key player in the global hotel industry, operating multiple hotel and apartment brands with coverage from luxury to economy markets. H World's brands include Hi Inn, HanTing Hotel, JI Hotel, Starway Hotel, Orange Hotel, Crystal Orange Hotel, Manxin Hotel, Madison Hotel, Joya Hotel, Blossom House, Ni Hao Hotel, CitiGO Hotel, Steigenberger Hotels & Resorts, MAXX, Jaz in the City, IntercityHotel, Zleep Hotels, Steigenberger Icon and Song Hotels.



Topic: Press release summary Sectors: Hospitality
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis  
Feb 6, 2026 19:56 HKT/SGT
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets  
Feb 6, 2026 17:45 HKT/SGT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 6, 2026 17:01 HKT/SGT
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization  
Feb 6, 2026 16:34 HKT/SGT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025  
Feb 6, 2026 13:13 HKT/SGT
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market  
Friday, February 6, 2026 12:34:00 PM
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market  
Feb 6, 2026 12:21 HKT/SGT
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors  
Feb 6, 2026 11:44 HKT/SGT
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products  
Friday, February 6, 2026 10:50:00 AM
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan  
Friday, February 6, 2026 10:31:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: